Prevalence of heart failure in the elderly and future projections: the AGES-Reykjavík study

Abstract

Objectives To assess the prevalence of heart failure (HF) in a randomly selected study population of elderly individuals representing the general population of Iceland. Furthermore, to project the number of individuals likely to have HF in the future. Design Baseline characteristics and clinical data from 5706 individuals who participated in the population based AGES-Reykjavik Study and gave their informed consent were used. Their age range was 66–98 years (mean age 77.0 ± 5.9 years), 57.6% were females. HF-diagnoses were established by review of hospital records and adjudicated according to prespecified criteria. Data from the ‘Statistics Iceland’ institution on the current size, age and sex distribution of the population and its prediction into the sixth decade were also used. Results The prevalence of HF was 3.6% in the sexes combined, but higher in men (5.1%) than women (2.7%) (p <.001). The prevalence of HF per age groups ≥69, 70–74, 75–79, 80–84 and ≥85 years was 1.7%, 1.5%, 3.7%, 5.2% and 7.2%, respectively. The number of individuals ≥70 years with HF will increase considerably in the future. Thus, a calculation based on the projected age distribution and increase in the number of elderly ≥70 years in the coming decades, demonstrated that the number of patients with HF will have increased 2.3-fold by the year 2040 and tripled by the year 2060. Conclusions This study, in a cohort of elderly participants representative of the general population in a Nordic country, predicts that HF will be a major and increasing health problem in the coming decades.

The Quality of Life of Seniors Hospitalized Due to Cardiovascular Diseases in Poland

“…It is a disease with a complex etiology and may be caused by many factors. Hypertension complications are the cause of 12.8% of all deaths worldwide [2,8]. Many studies have observed that in high-income countries, the percentage of people with hypertension is reduced due to the promotion of a healthy lifestyle and access to appropriate therapies [4,5,9,37,38].…”

“…In the study group, these were relatively rare, but other studies have shown that atherosclerosis is relatively common in adults; over time, it leads to clinically observable cardiovascular diseases, such as coronary artery disease, stroke, and peripheral atherosclerosis. These diseases are the main cause of death in Poland and around the world [2,3,7,8]. In Europe, cardiovascular diseases are responsible for around 40% of deaths before the age of 75 [2,5,41].…”

“…The results of the Global Burden of Disease Study indicate that cardiovascular disease has caused about 15.6 million deaths worldwide (29.6%). It is estimated that in Europe, cardiological diseases are the cause of 45% of all deaths, i.e., over 4 million per year [2,3,7,8].…”

Úr gögnum Hjartaverndar: Faraldsfræði kransæðasjúkdóma á Íslandi í hálfa öld

“…Reiknað er með að hjartabiluðum í hópi 70 ára og eldri eigi eftir að fjölga 2,3-falt fram til 2040 og þrefald-ast fyrir 2060. 52 Þá eru ótalin þau áhrif sem þessi þróun hefur á heilsutengd lífsgaeði og versnandi félagslega stöðu aldraðra sem lifa síðustu aeviárin við skerta faerni og minnkað sjálfstaeði, sem má að miklu leyti rekja til afleiðinga hjarta-og aeðasjúkdóma og annarra langvinnra sjúkdóma sem koma hefði mátt í veg fyrir með fyrirbyggjandi aðgerðum.…”

Na+–H+exchanger and proton channel in heart failure associated with Becker and Duchenne muscular dystrophies

“…Early death from heart failure (HF) is a major growing health problem in North America (Blair et al 2013;Danielsen et al 2017). There were nearly 5.7 million US Americans ≥ 20 years of age (2.7% prevalence) living with HF, and 670 000 new cases ≥ 45 years of age per year in 2008 in a population of about 304 million (Blair et al 2013;Roger et al 2012).…”